News Flash MAVIRET® (glecaprevir/pibrentasvir) was listed on the PBS in Australia today. AbbVie is pleased to announce that MAVIRET is to be listed on the PBS on 1 August 2018 for the treatment of chronic hepatitis C virus (HCV) infection in adults. MAVIRET is a new 8 week pangenotypic treatment for treatment-naïve non-cirrhotic HCV adult […]
Tag Archives: australia hepatitis c
In a surprising and warm-hearted gesture, the Australian government announced in December 2015 that they will pay for all Hepatitis C medications Australians need. They pledged a whole of $1 billion to the cause. The announcement came from Health Minister Sussan Ley, representing Turnbull's government. Hepatitis C in Australia by numbers According to Australian Hepatitis […]